PERIPHERAL ISCHEMIC RETINAL PHOTOCOAGULATION IN ADDITION TO INTRAVITREAL BEVACIZUMAB VERSUS INTRAVITREAL BEVACIZUMAB ALONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION-Reference-Cited by-同舟云学术

PERIPHERAL ISCHEMIC RETINAL PHOTOCOAGULATION IN ADDITION TO INTRAVITREAL BEVACIZUMAB VERSUS INTRAVITREAL BEVACIZUMAB ALONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION

Published:2020-06 Issue:6 Volume:40 Page:1110-1117
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Nourinia Ramin,Emamverdi Mehdi,Ramezani Alireza,Amizadeh Yashar,Khorshidifar Milad,Behnaz Nazanin,Safi Sare

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference20 articles.

1. Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts;Cugati;Ophthalmology,2007

2. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics;Hayreh;Am J Ophthalmol,1994

3. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study;Mitchell;Arch Ophthalmol,1996

4. The epidemiology of retinal vein occlusion: the beaver dam eye study;Klein;Trans Am Ophthalmol Soc,2000

5. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion;Boyd;Arch Ophthalmol,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the efficiency of anti-VEGF drugs intravitreal injections treatment with or without retinal laser photocoagulation for macular edema secondary to retinal vein occlusion: A systematic review and meta-analysis;Frontiers in Pharmacology;2022-07-22

2. Combination intravitreal anti-vascular endothelial growth factor inhibitors and macular laser photocoagulation relative to intravitreal injection monotherapy in macular oedema secondary to retinal vein occlusion: a meta-analysis of randomized controlled trials;Eye;2021-11-24

3. Outcomes of Eyes Lost to Follow-Up in Patients with Central Retinal Vein Occlusion Who are Receiving Anti-Vascular Endothelial Growth Factor Treatment;Therapeutics and Clinical Risk Management;2021-05

4. Retinal oximetry does not predict 12‐month visual outcome after anti‐VEGF treatment for central retinal vein occlusion: A multicentre study;Acta Ophthalmologica;2021-01-09

5. Investigation of clinical profile of Behçet's syndrome-related versus idiopathic branch retinal vein occlusion;Indian Journal of Ophthalmology;2020